Literature DB >> 24748221

Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe.

Riccardo Rubbiani1, Bettina Wahrig, Ingo Ott.   

Abstract

The medicinal chemistry and biomedical applications of gold complexes have been intensively studied over the last decades. Some complexes have been used for the treatment of rheumatoid arthritis, and a considerable number of new metallodrug candidates have been developed as new anticancer drugs and anti-infectives. However, the therapeutic use of gold and its complexes goes back to ancient times and was also of great importance for alchemists until the modern age. In this report, we give an overview of the alchemic medicine between the sixteenth and the early eighteenth century and describe the cytotoxicity and thioredoxin reductase (TrxR) inhibition of a typical "aurum vitae" medicine, which was prepared according to a recipe by Bartholomäus Kretschmar from the seventeenth century. "Aurum vitae" consists of a mixture of gold, mercury and antimony complexes and shows the expected cytotoxic and TrxR inhibitory properties providing some rationale for therapeutic effects of this kind of historical medicinal preparation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748221     DOI: 10.1007/s00775-014-1135-4

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  15 in total

1.  In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins.

Authors:  Raymond Wai-Yin Sun; Wing-Yiu Yu; Hongzhe Sun; Chi-Ming Che
Journal:  Chembiochem       Date:  2004-09-06       Impact factor: 3.164

Review 2.  Gold compounds as therapeutic agents for human diseases.

Authors:  Susan J Berners-Price; Aleksandra Filipovska
Journal:  Metallomics       Date:  2011-07-14       Impact factor: 4.526

3.  Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.

Authors:  Valentina Gandin; Aristi Potamitou Fernandes; Maria Pia Rigobello; Barbara Dani; Francesca Sorrentino; Francesco Tisato; Mikael Björnstedt; Alberto Bindoli; Alberto Sturaro; Rocco Rella; Cristina Marzano
Journal:  Biochem Pharmacol       Date:  2009-08-07       Impact factor: 5.858

Review 4.  Thioredoxin and thioredoxin reductase: current research with special reference to human disease.

Authors:  Arne Holmgren; Jun Lu
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

5.  Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.

Authors:  S Gromer; L D Arscott; C H Williams; R H Schirmer; K Becker
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

Review 6.  Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.

Authors:  Stefania Nobili; Enrico Mini; Ida Landini; Chiara Gabbiani; Angela Casini; Luigi Messori
Journal:  Med Res Rev       Date:  2010-05       Impact factor: 12.944

Review 7.  Chrysotherapy: a synoptic review.

Authors:  R Eisler
Journal:  Inflamm Res       Date:  2003-11-13       Impact factor: 4.575

8.  Molecular basis of antimony treatment in leishmaniasis.

Authors:  Paola Baiocco; Gianni Colotti; Stefano Franceschini; Andrea Ilari
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

9.  Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

Authors:  James L Hickey; Rasha A Ruhayel; Peter J Barnard; Murray V Baker; Susan J Berners-Price; Aleksandra Filipovska
Journal:  J Am Chem Soc       Date:  2008-08-26       Impact factor: 15.419

10.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08
View more
  1 in total

1.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.